Chondrocyte Cultivation in Hyaluronan-Tyramine Cross-Linked Hydrogel

Water-insoluble fibres, threads, and fabrics from lauroyl derivatives of hyaluronan

Hyaluronan (HA) is a naturally occurring polysaccharide widely used in medicine and cosmetics. To further broaden its potential, various HA derivatives have been developed with the aim of reducing solubility, slowing degradation, or providing other beneficial properties. However, for most medical applications, these derivatives must be processed into suitable forms. Here we present water-insoluble fibres prepared from lauroyl-modified HA using a wet spinning process. Important properties of the fibres, such as swelling or the degradation rate, can be fine-tuned by adjusting the degree of HA modification. Due to their mechanical properties, the lauroyl HA fibres can be easily processed into threads and subsequently into fabrics of various sizes, shapes, and degrees of porosity. In addition, in vitro cytotoxicity testing of the fibres showed that they were non-cytotoxic. Overall, our results suggest that lauroyl HA fibres are a promising material that could be used to develop a variety of medical devices.

Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair

Hydrogel scaffolds which bridge the lesion, together with stem cell therapy represent a promising approach for spinal cord injury (SCI) repair. In this study, a hydroxyphenyl derivative of hyaluronic acid (HA-PH) was modified with the integrin-binding peptide arginine-glycine-aspartic acid (RGD), and enzymatically crosslinked to obtain a soft injectable hydrogel. Moreover, addition of fibrinogen was used to enhance proliferation of human Wharton's jelly-derived mesenchymal stem cells (hWJ-MSCs) on HA-PH-RGD hydrogel. The neuroregenerative potential of HA-PH-RGD hydrogel was evaluated in vivo in acute and subacute models of SCI. Both HA-PH-RGD hydrogel injection and implantation into the acute spinal cord hemisection cavity resulted in the same axonal and blood vessel density in the lesion area after 2 and 8 weeks. HA-PH-RGD hydrogel alone or combined with fibrinogen (HA-PH-RGD/F) and seeded with hWJ-MSCs was then injected into subacute SCI and evaluated after 8 weeks using behavioural, histological and gene expression analysis. A subacute injection of both HA-PH-RGD and HA-PH-RGD/F hydrogels similarly promoted axonal ingrowth into the lesion and this effect was further enhanced when the HA-PH-RGD/F was combined with hWJ-MSCs. On the other hand, no effect was found on locomotor recovery or the blood vessel ingrowth and density of glial scar around the lesion. In conclusion, we have developed and characterized injectable HA-PH-RGD based hydrogel, which represents a suitable material for further combinatorial therapies in neural tissue engineering. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1129-1140, 2018.

Fabrication of cell-compatible hyaluronan hydrogels with a wide range of biophysical properties through high tyramine functionalization

Hyaluronan–tyramine derivatives are synthesized and the hydrogels obtained permit viable cell encapsulation with a wide range of mechanical properties.